The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone autograft to minimize hemarthrosis within the knee joint and post operative pain.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
POST-OPERATIVE HEMARTHROSIS
Timeframe: Post-operative week 1
POST-OPERATIVE Opioid Consumption
Timeframe: Days 1-7
POST-OPERATIVE Patient Reported Pain Score on the Visual Analog Scale (VAS)
Timeframe: Post-operative day 7